We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Commits to More Transparency When Authorizing COVID-19 Medicines
FDA Commits to More Transparency When Authorizing COVID-19 Medicines
FDA Commissioner Stephen Hahn pledged yesterday that the agency will publicly post detailed explanations of all Emergency Use Authorization (EUA) decisions, including all COVID-19 vaccine candidates now in the pipeline.